JP4338320B2 - ヌクレオシドジホスフェート及びトリホスフェートのためのアッセイ - Google Patents
ヌクレオシドジホスフェート及びトリホスフェートのためのアッセイ Download PDFInfo
- Publication number
- JP4338320B2 JP4338320B2 JP2000616383A JP2000616383A JP4338320B2 JP 4338320 B2 JP4338320 B2 JP 4338320B2 JP 2000616383 A JP2000616383 A JP 2000616383A JP 2000616383 A JP2000616383 A JP 2000616383A JP 4338320 B2 JP4338320 B2 JP 4338320B2
- Authority
- JP
- Japan
- Prior art keywords
- ndpk
- nucleoside
- adp
- atp
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002777 nucleoside Substances 0.000 title claims abstract description 37
- -1 nucleoside diphosphates Chemical class 0.000 title claims abstract description 36
- 239000001177 diphosphate Substances 0.000 title claims abstract description 26
- 235000011180 diphosphates Nutrition 0.000 title claims abstract description 26
- 239000001226 triphosphate Substances 0.000 title claims abstract description 18
- 235000011178 triphosphate Nutrition 0.000 title claims abstract description 18
- 238000003556 assay Methods 0.000 title description 9
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 title description 3
- 102000013901 Nucleoside diphosphate kinase Human genes 0.000 claims abstract description 72
- 101710100179 UMP-CMP kinase Proteins 0.000 claims abstract description 69
- 101710119674 UMP-CMP kinase 2, mitochondrial Proteins 0.000 claims abstract description 69
- 102000004190 Enzymes Human genes 0.000 claims abstract description 39
- 108090000790 Enzymes Proteins 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000008859 change Effects 0.000 claims abstract description 14
- 238000001727 in vivo Methods 0.000 claims abstract description 5
- 238000000338 in vitro Methods 0.000 claims abstract description 4
- 102000009097 Phosphorylases Human genes 0.000 claims description 25
- 108010073135 Phosphorylases Proteins 0.000 claims description 25
- OGQHCUYSWDOIMP-UHFFFAOYSA-N 7-(diethylamino)-n-[2-[(2-iodoacetyl)amino]ethyl]-2-oxochromene-3-carboxamide Chemical compound C1=C(C(=O)NCCNC(=O)CI)C(=O)OC2=CC(N(CC)CC)=CC=C21 OGQHCUYSWDOIMP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 230000000865 phosphorylative effect Effects 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 9
- 241000863422 Myxococcus xanthus Species 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 4
- 238000004445 quantitative analysis Methods 0.000 claims 1
- 238000006209 dephosphorylation reaction Methods 0.000 abstract description 21
- 230000030609 dephosphorylation Effects 0.000 abstract description 17
- 238000006366 phosphorylation reaction Methods 0.000 abstract description 10
- 230000026731 phosphorylation Effects 0.000 abstract description 8
- 238000005259 measurement Methods 0.000 abstract description 7
- 238000002372 labelling Methods 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 239000000523 sample Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 239000000872 buffer Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 210000001087 myotubule Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 102100027609 Rho-related GTP-binding protein RhoD Human genes 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000007990 PIPES buffer Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 5
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 101150064469 ndk gene Proteins 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101100518359 Homo sapiens RHO gene Proteins 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- 239000012614 Q-Sepharose Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000003833 nucleoside derivatives Chemical class 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 231100000582 ATP assay Toxicity 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 2
- 108010043137 Actomyosin Proteins 0.000 description 2
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000003505 Myosin Human genes 0.000 description 2
- 108030001204 Myosin ATPases Proteins 0.000 description 2
- 108700023477 Nucleoside diphosphate kinases Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- VMJKUPWQKZFFCX-UHFFFAOYSA-N coumarin 504 Chemical compound C1CCC2=C(OC(C(C(=O)OCC)=C3)=O)C3=CC3=C2N1CCC3 VMJKUPWQKZFFCX-UHFFFAOYSA-N 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011897 real-time detection Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- IXQPRUQVJIJUEB-UHFFFAOYSA-N 7-(diethylamino)-n-[2-(2,5-dioxopyrrol-1-yl)ethyl]-2-oxochromene-3-carboxamide Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C=C1C(=O)NCCN1C(=O)C=CC1=O IXQPRUQVJIJUEB-UHFFFAOYSA-N 0.000 description 1
- 102000003736 ATP Synthetase Complexes Human genes 0.000 description 1
- 108010082072 ATP Synthetase Complexes Proteins 0.000 description 1
- 102000007347 Apyrase Human genes 0.000 description 1
- 108010007730 Apyrase Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102220568857 F-box/LRR-repeat protein 2_D62C_mutation Human genes 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102100023252 Nucleoside diphosphate kinase A Human genes 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102000011929 Succinate-CoA Ligases Human genes 0.000 description 1
- 108010075728 Succinate-CoA Ligases Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108030003004 Triphosphatases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- UOLVQBSMMHANLG-XZNUSECASA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [hydroxy-[1-(2-nitrophenyl)ethoxy]phosphoryl] hydrogen phosphate Chemical compound C([C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC(C)C1=CC=CC=C1[N+]([O-])=O UOLVQBSMMHANLG-XZNUSECASA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KNYAHOBESA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphoryl hydrogen phosphate Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[32P](O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KNYAHOBESA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007813 chromatographic assay Methods 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- DAEAPNUQQAICNR-RRKCRQDMSA-K dADP(3-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])([O-])=O)O1 DAEAPNUQQAICNR-RRKCRQDMSA-K 0.000 description 1
- FTDHDKPUHBLBTL-SHYZEUOFSA-K dCDP(3-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 FTDHDKPUHBLBTL-SHYZEUOFSA-K 0.000 description 1
- CIKGWCTVFSRMJU-KVQBGUIXSA-N dGDP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 CIKGWCTVFSRMJU-KVQBGUIXSA-N 0.000 description 1
- UJLXYODCHAELLY-XLPZGREQSA-N dTDP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 UJLXYODCHAELLY-XLPZGREQSA-N 0.000 description 1
- QHWZTVCCBMIIKE-SHYZEUOFSA-K dUDP(3-) Chemical compound O1[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 QHWZTVCCBMIIKE-SHYZEUOFSA-K 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- SJFPWBFXBOZGTB-ONEGZZNKSA-N desdanine Chemical compound NC(=O)\C=C\C1=NCCC1 SJFPWBFXBOZGTB-ONEGZZNKSA-N 0.000 description 1
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003473 flash photolysis reaction Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000001738 isopycnic centrifugation Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229940102859 methylene diphosphonate Drugs 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108091006026 monomeric small GTPases Proteins 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- OJBZDUMTXGGVSP-KTKRTIGZSA-N n-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C=C1C(=O)N\C=C/N1C(=O)CCC1=O OJBZDUMTXGGVSP-KTKRTIGZSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 125000005642 phosphothioate group Chemical group 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002097 psoas muscle Anatomy 0.000 description 1
- 238000007420 radioactive assay Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 102000030938 small GTPase Human genes 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9910811.0 | 1999-05-10 | ||
| GBGB9910811.0A GB9910811D0 (en) | 1999-05-10 | 1999-05-10 | Assays |
| PCT/GB2000/001740 WO2000068418A1 (en) | 1999-05-10 | 2000-05-05 | Assays for nucleoside diphosphates and triphospates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002543798A JP2002543798A (ja) | 2002-12-24 |
| JP2002543798A5 JP2002543798A5 (https=) | 2009-07-02 |
| JP4338320B2 true JP4338320B2 (ja) | 2009-10-07 |
Family
ID=10853167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000616383A Expired - Fee Related JP4338320B2 (ja) | 1999-05-10 | 2000-05-05 | ヌクレオシドジホスフェート及びトリホスフェートのためのアッセイ |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6746849B1 (https=) |
| EP (1) | EP1177314B1 (https=) |
| JP (1) | JP4338320B2 (https=) |
| AT (1) | ATE264400T1 (https=) |
| AU (1) | AU771858B2 (https=) |
| CA (1) | CA2371176C (https=) |
| DE (1) | DE60009891T2 (https=) |
| GB (1) | GB9910811D0 (https=) |
| WO (1) | WO2000068418A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4431334B2 (ja) | 2003-07-29 | 2010-03-10 | 独立行政法人科学技術振興機構 | 改良されたａｔｐの増幅方法およびその利用 |
| GB0711328D0 (en) * | 2007-06-12 | 2007-07-25 | Medical Res Council | Biosensor for detection and visualisation of single-stranded dna |
| GB0817166D0 (en) * | 2008-09-19 | 2008-10-29 | Medical Res Council | Sensor |
| CN103031287B (zh) * | 2012-12-10 | 2014-12-10 | 浙江工业大学 | 冬虫夏草中国被毛孢二磷酸核苷激酶、编码基因及其应用 |
| GB201505266D0 (en) * | 2015-03-27 | 2015-05-13 | Medical Res Council | ATP sensor |
| CN106290166A (zh) * | 2016-09-20 | 2017-01-04 | 江南大学 | 一种细胞内atp的圆二色光谱实时检测方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2834704A1 (de) * | 1978-08-08 | 1980-02-21 | Boehringer Mannheim Gmbh | Verfahren zur quantitativen enzymatischen bestimmung von adp |
| IT1172385B (it) * | 1983-12-21 | 1987-06-18 | Miles Italiana | Composizione e metodo per la determinazione enzimatica di atp ed fmn |
| FR2660933A1 (fr) | 1990-04-12 | 1991-10-18 | Pasteur Institut | Moyens pour la detection de cellules hautement proliferatives. |
| US5741635A (en) | 1996-01-30 | 1998-04-21 | Mount Sinai Hospital Corporation | Method of quantitating GTP and GDP bound to a G protein and uses thereof |
| WO2000052467A1 (en) * | 1999-03-02 | 2000-09-08 | The University Of Dundee | Methods of determining altered ndpk functions |
-
1999
- 1999-05-10 GB GBGB9910811.0A patent/GB9910811D0/en not_active Ceased
-
2000
- 2000-05-05 JP JP2000616383A patent/JP4338320B2/ja not_active Expired - Fee Related
- 2000-05-05 WO PCT/GB2000/001740 patent/WO2000068418A1/en not_active Ceased
- 2000-05-05 AT AT00927529T patent/ATE264400T1/de not_active IP Right Cessation
- 2000-05-05 DE DE60009891T patent/DE60009891T2/de not_active Expired - Lifetime
- 2000-05-05 CA CA002371176A patent/CA2371176C/en not_active Expired - Lifetime
- 2000-05-05 EP EP00927529A patent/EP1177314B1/en not_active Expired - Lifetime
- 2000-05-05 AU AU45923/00A patent/AU771858B2/en not_active Ceased
- 2000-05-05 US US09/937,296 patent/US6746849B1/en not_active Expired - Lifetime
-
2004
- 2004-02-18 US US10/779,718 patent/US7297506B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU771858B2 (en) | 2004-04-01 |
| DE60009891T2 (de) | 2005-04-21 |
| CA2371176C (en) | 2008-12-23 |
| EP1177314B1 (en) | 2004-04-14 |
| EP1177314A1 (en) | 2002-02-06 |
| GB9910811D0 (en) | 1999-07-07 |
| US7297506B2 (en) | 2007-11-20 |
| JP2002543798A (ja) | 2002-12-24 |
| WO2000068418A1 (en) | 2000-11-16 |
| US20040248079A1 (en) | 2004-12-09 |
| AU4592300A (en) | 2000-11-21 |
| ATE264400T1 (de) | 2004-04-15 |
| DE60009891D1 (en) | 2004-05-19 |
| CA2371176A1 (en) | 2000-11-16 |
| US6746849B1 (en) | 2004-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paraskevopoulou et al. | The elongator subunit Elp3 contains a Fe4S4 cluster and binds S‐adenosylmethionine | |
| CN1612937B (zh) | 用于高半胱氨酸和胱硫醚的酶促循环测定 | |
| Krepkiy et al. | Identification of active site residues in mevalonate diphosphate decarboxylase: implications for a family of phosphotransferases | |
| Neumann et al. | Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli | |
| Collazo et al. | A coupled fluorescent assay for histone methyltransferases | |
| Wyckoff et al. | The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase: chemical modification and site-directed mutagenesis | |
| Zhang et al. | IscS functions as a primary sulfur-donating enzyme by interacting specifically with MoeB and MoaD in the biosynthesis of molybdopterin in Escherichia coli | |
| Sakai et al. | ATPase activity and multimer formation of PilQ protein are required for thin pilus biogenesis in plasmid R64 | |
| JP4338320B2 (ja) | ヌクレオシドジホスフェート及びトリホスフェートのためのアッセイ | |
| Curien et al. | Allosteric monofunctional aspartate kinases from Arabidopsis | |
| Studer et al. | Properties of the methylcobalamin: H4folate methyltransferase involved in chloromethane utilization by Methylobacterium sp. strain CM4 | |
| Srivastava et al. | Structural characterization of ribT from Bacillus subtilis reveals it as a GCN5-related N-acetyltransferase | |
| Brune et al. | A fluorescent sensor of the phosphorylation state of nucleoside diphosphate kinase and its use to monitor nucleoside diphosphate concentrations in real time | |
| JP5058422B2 (ja) | 高比活性組み換えｓ−アデノシルホモシステイナーゼ（ｓａｈｈ）の高発現および製造並びにｓ−アデノシルメチオニン（ｓａｍ）の改善されたアッセイ | |
| Hasegawa et al. | Functional characterization of aminotransferase involved in serine and aspartate metabolism in a halotolerant cyanobacterium, Aphanothece halophytica | |
| EP1230381B1 (en) | Enzymatic cycling assays for homocysteine and cystathionine | |
| Jiang et al. | Development of the IMP biosensor for rapid and stable analysis of IMP concentrations in fermentation broth | |
| CA2516029A1 (en) | Method of measuring homocysteine | |
| Adina-Zada et al. | Insights into the mechanism and regulation of pyruvate carboxylase by characterisation of a biotin-deficient mutant of the Bacillus thermodenitrificans enzyme | |
| Kiyonari et al. | A single amino acid substitution in the DNA-binding domain of Aeropyrum pernix DNA ligase impairs its interaction with proliferating cell nuclear antigen | |
| Qin et al. | Preparation and characterization of a single-chain calcineurin–calmodulin complex | |
| Lu et al. | Histidine 89 is an essential residue for Hsp70 in the phosphate transfer reaction | |
| Lu‐Chang | Isolation and analyses of MutY homologs (MYH) | |
| Yun | Characterization of the human atypical kinase, Aarf domain-containing kinase 3, and its substrates required for coenzyme Q biosynthesis | |
| Georgiev | Histidine kinases and response regulators in Methanosarcina acetivorans: Structural and functional insights into archaeal signalling networks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051108 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051108 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081014 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090406 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20090428 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090601 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090630 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120710 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |